HIV-1 integrase and RNase H activities as therapeutic targets

Author： Andréola ML De Soultrait V Richard Fournier M Parissi V Desjobert C Litvak S

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.6, Iss.4, 2002-08, pp. : 433-446

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Peptide Motifs Against HIV-1 Reverse Transcriptase and Integrase

Current Pharmaceutical Design, Vol. 15, Iss. 21, 2009-07 ,pp. : 2508-2519

Bentham Science Publishers

Access to resources Recommend Favorite

Diketo Acids Derivatives as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain

Current Medicinal Chemistry, Vol. 18, Iss. 22, 2011-08 ,pp. : 3335-3342

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting HIV-1 integrase

By Yelle Jocelyn Sauvé Gilles Sayasith Khampoune

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. : 443-464

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Research of HIV-1 RNase H Inhibitors

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-10 ,pp. : 1243-1251

Bentham Science Publishers

Access to resources Recommend Favorite

Ubiquitin ligases as therapeutic targets in HIV-1 infection

By Votteler Jörg Schubert Ulrich

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 131-143

Informa Healthcare

Access to resources Recommend Favorite